These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7266775)

  • 21. Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to effects of ceruletide in chronically haloperidol-treated rats.
    Hagino Y; Okuwa M; Moroji T
    Neuropeptides; 1991 Jan; 18(1):1-14. PubMed ID: 2046884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic inhibition of pituitary beta-endorphin-like immunoreactivity secretion in the rat.
    Farah JM; Malcolm DS; Mueller GP
    Endocrinology; 1982 Feb; 110(2):657-9. PubMed ID: 6276143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
    Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW
    Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.
    Sands SA; Dickerson DS; Morris SJ; Chronwall BM
    Endocrine; 1997 Jun; 6(3):325-33. PubMed ID: 9368690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary sensitivity to gonadotrophin releasing hormone after hyperprolactinaemia induced with neuroleptics and domperidone in the rat.
    Carter DA; Whitehead SA
    J Endocrinol; 1981 Dec; 91(3):439-46. PubMed ID: 7035595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some functional aspects of canine corticotrophs.
    Middleton DJ; Rijnberk A; Bevers MM; Goos HJ; Beeftink EA; Thijssen JH; Croughs RJ
    Horm Metab Res; 1987 Dec; 19(12):632-5. PubMed ID: 2831126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
    Dutt A; Juneja HS
    Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B; Dannies PS
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of prolactin-secreting effect produced by repeated administration of haloperidol in the avoidance situation and dopamine neurons in rats.
    Hayashi T; Kifune A; Tadokoro S
    Jpn J Pharmacol; 1988 Nov; 48(3):387-90. PubMed ID: 3221537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of prolactin in the onset of puberty in female rats.
    Gonzalez MD; López F; Aguilar E
    J Endocrinol; 1984 Apr; 101(1):63-8. PubMed ID: 6538590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
    Flores CM; Hulihan-Giblin BA; Hornby PJ; Lumpkin MD; Kellar KJ
    Neuroendocrinology; 1992 May; 55(5):519-28. PubMed ID: 1350068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats.
    Tilders FJ; Smelik PG
    Neuroendocrinology; 1978; 25(5):275-90. PubMed ID: 206853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norepinephrine content in the paraventicular nucleus of the hypothalamus as a function of photoperiod and dopaminergic tone.
    Woods KA; Buechi KA; Illig AM; Badura LL
    Endocrine; 1998 Feb; 8(1):79-83. PubMed ID: 9666349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for central nervous system (CNS) involvement in inhibition of luteinizing hormone (LH) release by dopamine receptor stimulation.
    Owens RE; Fleeger JL; Harms PG
    Endocr Res Commun; 1980; 7(2):99-105. PubMed ID: 6997016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine inhibits 32P incorporation into phosphatidylinositol in the anterior pituitary gland of the rat.
    Canonico PL; Valdenegro CA; Macleod RM
    Endocrinology; 1982 Jul; 111(1):347-9. PubMed ID: 7084120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence in favour of the existence of a dopamine-free prolactin-inhibiting factor (PIF) in rat hypothalamic extracts.
    Enjalbert A; Priam M; Kordon C
    Eur J Pharmacol; 1977 Jan; 41(2):243-4. PubMed ID: 12991
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopaminergic modulation of nNOS expression in the pituitary gland of male rat.
    Carretero J; Weruaga E; Hernández E; Burks D; Riesco JM; Rubio M; Briñón JG; Aijón J; Vázquez R; Alonso JR
    Anat Embryol (Berl); 2003 Dec; 207(4-5):381-8. PubMed ID: 14618399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pimozide and bromocriptine on the proliferation of rat pituitary pars intermedia cells.
    Rychter J; Stepień H
    J Endocrinol; 1977 Dec; 75(3):443-4. PubMed ID: 591856
    [No Abstract]   [Full Text] [Related]  

  • 39. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
    Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T
    Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor.
    Xu R; Parlow AF; Wang Y
    Brain Res; 2002 Jun; 939(1-2):95-9. PubMed ID: 12020855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.